Dwarfism and the controversial drug trial | SBS Dateline

Achondroplasia, the most common form of dwarfism, is a rare genetic disorder that impacts bone growth, affecting around 1 in 25,000 children worldwide.
Australian researchers are leading a global drug trial aimed at boosting growth in children born with a form of dwarfism.
But some people of short stature are scared it will eradicate their community.
This episode first aired in 2021.
Subscribe to Dateline: bit.ly/3gkQHtr
Website www.sbs.com.au/news/dateline
Facebook / datelinesbs
Twitter / datelinesbs
Instagram / datelinesbs
Watch more Dateline, SBS 9.30pm Tuesday, and on SBS On Demand.
Dateline is an Australian award-winning international documentary series with a current affairs backbone.
Every week we transport you to a different part of the world to share half-hour stories about family, social injustice, identity, tragedy, redemption and survival. We scour the globe to bring you special characters and a world of daring stories.
Network Terms & Conditions: www.sbs.com.au/terms
Privacy Policy: www.sbs.com.au/privacy
Feedback or complaints: www.sbs.com.au/complaints